Castle Creek Biosciences, Inc. Uncategorized Contracts & Agreements
6 Contracts & Agreements
- Letter Agreement, dated June 9, 2021, by and between Paragon Health Capital, LLC and Castle Creek Biosciences, Inc (Filed With SEC on July 16, 2021)
- Right of Use Agreement, dated November 1, 2019, by and between Paragon Biosciences, LLC and Castle Creek Pharmaceuticals, LLC (Filed With SEC on July 16, 2021)
- Letter of Agreement, dated February 19, 2020, by and between the Registrant (formerly entered into by Fibrocell Science, Inc.) and Precigen, Inc (Filed With SEC on July 16, 2021)
- Offer Letter, dated February 11, 2021, by and between the Registrant and Matthew Gantz (Filed With SEC on July 16, 2021)
- Offer Letter, dated April 9, 2019, by and between the Registrant and Mary Spellman (Filed With SEC on July 16, 2021)
- Offer Letter, dated September 27, 2016, by and between the Registrant and Gregory Wujek (Filed With SEC on July 16, 2021)